Tag: daxibotulinumtoxina

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection
Aesthetic Surgeon Shares Insights on DAXI’s Potential
Letybo, a Botulinum Toxin Recently Approved in US, Expands to Malaysia

All

Sorry, No Posts Found

All

Allergan Aesthetics Introduces Skin Quality Index to Standardize Patient-Provider Communication

New framework aims to address inconsistencies in how skin quality is described during aesthetic consultations.

Terri Ross Consulting Launches Fractional CFO Advisory Service for Medical Aesthetic Practices
‘Plastic Surgery Deserts’ Emerging as Demand Grows in Underserved US Regions
Survey Finds Americans Prioritizing Aesthetic Treatments Over Everyday Spending

Tag: daxibotulinumtoxina

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection

Aesthetic Surgeon Shares Insights on DAXI’s Potential

Letybo, a Botulinum Toxin Recently Approved in US, Expands to Malaysia

All

Sorry, No Posts Found

All

Allergan Aesthetics Introduces Skin Quality Index to Standardize Patient-Provider Communication

Terri Ross Consulting Launches Fractional CFO Advisory Service for Medical Aesthetic Practices

‘Plastic Surgery Deserts’ Emerging as Demand Grows in Underserved US Regions

Survey Finds Americans Prioritizing Aesthetic Treatments Over Everyday Spending

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links